Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 7:53 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Point72 Asset Management L.P. | 1,760,207 9.600% | 1,002,022 (+132.16%) | View |
2024-11-14 5:50 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Venrock Healthcare Capital Partners III L.P. | 906,486 5.000% | 82,860 (+10.06%) | View |
2024-11-14 5:46 pm Sale | 13G | Praxis Precision Medicines Inc. PRAX | RA CAPITAL MANAGEMENT L.P. | 761,955 4.300% | -473,644 (-38.33%) | View |
2024-11-14 3:08 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Cormorant Asset Management LP | 1,140,000 4.670% | 506,655 (+80.00%) | View |
2024-11-14 1:22 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | PRICE T ROWE ASSOCIATES INC | 1,120,080 6.300% | 1,120,080 (New Position) | View |
2024-11-14 09:23 am Sale | 13G | Praxis Precision Medicines Inc. PRAX | Verition Fund Management LLC | 314,294 1.800% | -388,685 (-55.29%) | View |
2024-11-12 4:47 pm Unchanged | 13G | Praxis Precision Medicines Inc. PRAX | VANGUARD GROUP INC | 1,038,994 5.850% | 0 (Unchanged) | View |
2024-11-12 1:29 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Capital Research Global Investors | 997,094 5.600% | 997,094 (New Position) | View |
2024-11-12 09:35 am Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Adage Capital Management L.P. | 854,083 4.810% | 854,083 (New Position) | View |
2024-11-08 2:17 pm Unchanged | 13G | Praxis Precision Medicines Inc. PRAX | BlackRock Inc. | 1,302,435 7.300% | 0 (Unchanged) | View |
2024-11-04 1:41 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | VANGUARD GROUP INC | 1,038,994 5.850% | 1,038,994 (New Position) | View |
2024-10-22 3:24 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | BlackRock Inc. | 1,302,435 7.300% | 1,302,435 (New Position) | View |
2024-09-23 5:42 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | PERCEPTIVE ADVISORS LLC | 1,119,035 6.300% | 1,119,035 (New Position) | View |
2024-07-01 9:31 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | RA CAPITAL MANAGEMENT L.P. | 1,235,599 7.200% | 1,235,599 (New Position) | View |
2024-02-14 8:45 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Venrock Healthcare Capital Partners III L.P. | 823,626 8.900% | 823,626 (New Position) | View |
2024-02-14 4:12 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Point72 Asset Management L.P. | 758,185 8.600% | 758,185 (New Position) | View |
2024-02-14 4:06 pm Sale | 13G | Praxis Precision Medicines Inc. PRAX | PFM Health Sciences LP | 656,548 0.500% | -2,120,919 (-76.36%) | View |
2024-02-14 3:05 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Cormorant Asset Management LP | 633,345 7.390% | 633,345 (New Position) | View |
2024-02-14 12:21 pm Unchanged | 13G | Praxis Precision Medicines Inc. PRAX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | View |
2024-02-14 10:01 am Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Tri Locum Partners LP | 248,761 2.800% | 248,761 (New Position) | View |